A Study to Explore the Effect of SP-624 on Brain Network Analytics in Healthy Adults and Adults With Major Depression

Clinical trial NCT06570369 · COMPLETED

Trial details

NCT number: NCT06570369
Sponsor: Sirtsei Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Major Depressive Disorder Depression Healthy

Start date: 2024-08-22
Primary completion: 2026-05-11
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.